Spondylarthritis Clinical Trial
Official title:
Multi-omics Study and Drug Intervention Study of Spondyloarthritis
Spondyloarthritis (SpA) is a type of chronic inflammatory rheumatic disease that mainly affects the spine and peripheral joints, or joints, ligaments and tendons. This disease subtype has the same clinical and immunological features. Further explore the pathogenesis of spondyloarthritis, explore the guiding significance of different imaging examinations for spondyloarthritis, and study the efficacy and mechanism of different drugs for spondyloarthritis.
1. Clinical phenotype research. The clinical phenotype is the symptoms and signs of the disease and its evolution. Through the clinical phenotype research of spondyloarthritis, it is helpful to realize the diagnosis and grading of spondyloarthritis and help to achieve individualization Precise treatment. 2. Transcriptomic research. The key genes and pathways involved in the pathogenesis of spondyloarthritis can be explored through transcriptomic research of spondyloarthritis, which can provide help for early diagnosis and seeking potential treatment methods. 3. Microbiological research. Through the microbiome research on spondyloarthritis, the composition and function of intestinal flora in patients with spondyloarthritis can be deeply analyzed to provide help for diagnosis and treatment. 4. Radiomics research. Through the radiomics research on spondyloarthritis, it is helpful to realize the diagnosis and grading of spondyloarthritis and the evaluation and prediction of treatment. 5. Drug treatment research By studying the therapeutic effects of different drugs in patients with spondyloarthritis, it is helpful to explore the efficacy and mechanism of different drugs on spondyloarthritis, and to achieve precise and individualized treatment. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03818958 -
Seric Calprotectine in Spondyloarthritis
|
||
| Not yet recruiting |
NCT03940911 -
Fatigue and Skeletal Muscle Impact in Severe Axial Spondylarthritis
|
N/A | |
| Completed |
NCT01947465 -
Immunogenicity and Safety of Vaccinations in Immunocompromised Persons
|
N/A | |
| Recruiting |
NCT05926453 -
Assessment of Cardiorespiratory Fitness in Spondylarthritis
|
||
| Recruiting |
NCT05080218 -
COVID-19 VaccinE Response in Rheumatology Patients
|
Phase 4 | |
| Terminated |
NCT03454932 -
Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases
|
||
| Completed |
NCT01314547 -
Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env Cohort
|
N/A | |
| Not yet recruiting |
NCT06273306 -
Towards Telemonitoring in Immune-Mediated Inflammatory Diseases: Implementation of a Mixed Attention Model (IMIDOC)
|
N/A | |
| Recruiting |
NCT02809781 -
A Pilot Study of MSCs Iufusion and Etanercept to Treat Ankylosing Spondylitis
|
Phase 2/Phase 3 | |
| Completed |
NCT02098694 -
Physiotherapy-led Outpatient Clinic for Patients With Spondyloarthritis
|
N/A | |
| Recruiting |
NCT00491933 -
Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα Antagonists
|
N/A | |
| Enrolling by invitation |
NCT04964661 -
Incidence of MRI Sacro-Iliac (SI) Joint Anomalies in Women With Spondyloarthritis (SpA)
|
||
| Completed |
NCT02473315 -
Assessment of Whole Body Cryotherapy in Treatment of Active Axial Spondylarthritis
|
N/A | |
| Completed |
NCT03999489 -
Study of the Psychometric Properties and a Measure of Utility Determinants ( the SF- 6D) in Patients With Early Inflammatory Low Back Pain
|
||
| Recruiting |
NCT04519866 -
Clinical Trial of Electroacupuncture in Axial Spondyloarthritis (E-AcuSpA)
|
N/A | |
| Completed |
NCT02402894 -
Follow-up of Person-centered Care of Young Adults With Rheumatic Disease
|
||
| Recruiting |
NCT05592574 -
IL17 Rate and Spondyloarthritis
|
||
| Completed |
NCT02988674 -
A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation
|
||
| Recruiting |
NCT05555433 -
Calprotectine in Spondyloarthritis
|
||
| Completed |
NCT01302730 -
Ankylosing Spondylitis and Spondyloarthritis Evaluation Tool Study
|
N/A |